S0292 Impact of Antithrombotic Therapy (ATT) on Screening of Colorectal Cancer in Ecuador

Abstract:

METHODS: We retrospectively studied the patients who pathologically diagnosed CRC in our country between July 2015 to February 2020. Bleeding related symptoms and TNM-stage were compared between patients with CRC receiving antiplatelet therapy, anticoagulant therapy, multi-ATT (eg, dual antiplatelet drug or antiplatelet drugs plus anticoagulant drugs), and non-ATT. Bleeding related symptoms were defined as overt bleeding (hematochezia, melena, and rectal bleeding), positive fecal blood test and anemia. RESULTS: A total of 1114 patients with CRC were analyzed. Of these, 218 patients were included in antiplatelet therapy group, 109 patients in anticoagulant therapy group, 101 patients in multi-ATT and 686 patients in non-ATT group. With regard to reasons for work up of CRC, the rate of bleeding related symptoms in antiplatelet therapy group (54%, P= 0.038), antithrombotic therapy group (62%, P …

Año de publicación:

2020

Keywords:

Fuente:

google